Site content: Global

Press Release

DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor

Results presented at the 2020 San Antonio Breast Cancer Symposium confirm the relevance of screening for HER2+ CTCs from blood samples in patients with a HER2 negative primary tumor...

New Global Pooled Analysis Supports Clinical Utility of Circulating Tumor Cell Count for Early Monitoring of Metastatic Breast Cancer

Robust pooled analysis demonstrating how CTC count may help to optimize treatment choices   BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., December 9, 2020 -- Menarini...